Related keylists
Strides Pharma Science Ltd (Strides Pharma), formerly Strides Shasun Ltd, develops and manufactures finished dosage formulations and generic pharmaceutical products. The company manufactures soft and hard gelatin capsules, tablets, oral liquids, powders, topicals and other generic products. Strides Pharma drugs are used to treat AIDS, tuberculosis, malaria, leprosy, h1n1, covid-19, hepatitis and other infectious diseases. The company works in collaboration with other organizations to develop its products. Its products are available as over-the-counter drugs and prescription drugs. Strides Pharma is headquartered in Bangalore, Karnataka, India.
Headquarters
India
Address
Strides House, Bannerghatta Road, Bilekahalli, Bangalore, Karnataka, 560076
Website
www.strides.com
Telephone
91 80 67840000
No of Employees
2,850
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
STAR (NSE)
Revenue (2022)
$470.0M
20.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
56%
(2022 vs 2021)
Market Cap*
$926.7M
Net Profit Margin (2022)
XYZ
63.4%
(2022 vs 2021)
* As of and is in US$
Strides Pharma Science Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Finished Dosage Formulations: | CellCept |
| Soft Gelatin Capsules | Aldara |
| Tablets | Oxsoralen-Ultra |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Plans/Strategy | In September, the company announced its plans to spin off its contract development and manufacturing organisation and soft gelatin business to form OneSource. |
| 2023 | Contracts/Agreements | In May, the company signed a partnership with Orbicular Pharmaceutical Technologies Private Limited to manufacture, develop, and commercialize nasal sprays for the global markets. |
| 2022 | Regulatory Approval | In March, the company's Strides Pharma Global Pte. Limited, secured approval from the USFDA for its Colchicine Tablets USP, 0.6 mg. |
Competitor Comparison
| Key Parameters | Strides Pharma Science Ltd | Aurobindo Pharma Ltd | Cipla Ltd | Glenmark Pharmaceuticals Ltd | Torrent Pharmaceuticals Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Bangalore | Hyderabad | Mumbai | Mumbai | Ahmedabad |
| State/Province | Karnataka | Telangana | Maharashtra | Maharashtra | Gujarat |
| No. of Employees | 2,850 | 15,690 | 26,615 | 15,556 | 13,573 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Arun Kumar | Managing Director; Chairman | Executive Board | 2022 | - |
| Badree Komandur | Director; Chief Financial Officer | Executive Board | 2010 | - |
| Umesh Kale | Chief Quality Officer | Senior Management | - | - |
| Christoph Funke | Chief Operations Officer | Senior Management | - | - |
| S. Sridhar | Director | Non Executive Board | 2012 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward